Delivery Order SPE2DB25D3109-SPE2DB25FP4MS
- Not listed
- The Defense Logistics Agency awarded a $14,510.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for TREMFYA 200 mg/2 mL pen injections. This is a non-set-aside competitive award with a completion date of September 4, 2025, and represents performance at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for TREMFYA 200 mg/2 mL pen injections valued at $14,510.52 under a firm fixed price contract. The delivery order, issued on September 8, 2025, has an ultimate completion date of September 29, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This is a non-set-aside award issued through open competition, reflecting AmerisourceBergen's established...
- The Defense Logistics Agency awarded a $21,765.75 delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of TREMFYA 200 mg/2 mL pen injections. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 28, 2025. The pharmaceutical product will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a $7,255.25 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of TREMFYA 200 mg/2 mL pen injections. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement and is scheduled for completion by July 30, 2025. The award will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of TREMFYA 200 mg/2 mL pens valued at $21,765.75 under a firm fixed-price contract structure. This competitively awarded, non-set-aside delivery order is scheduled for completion by August 5, 2025, with performance based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order is issued under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order valued at $14,691.41 to AmerisourceBergen Drug Corp for TREMFYA 100 MG/ML, a prescription pharmaceutical product. The contract, issued on July 31, 2025, with an ultimate completion date of August 1, 2025, utilizes firm fixed pricing and carries no set-aside designation, indicating it was competitively awarded. Performance will occur at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a $11,751.35 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of TREMFYA 100 mg/ml (one-press ml unit). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 20, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of TREMFYA 200 mg/2 ml pen injections valued at $7,255.25. This firm fixed-price, competitively awarded delivery order carries an ultimate completion date of September 4, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The contract represents a non-set-aside procurement, indicating the award was made through open...
- The Defense Logistics Agency awarded a $19,006 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TREMFYA 100 mg/ml pharmaceutical products on August 5, 2025, with an ultimate completion date of August 6, 2025. This non-set-aside competitive award is performed at the contractor's location in Conshohocken, Pennsylvania. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $19,720.27 to AmerisourceBergen Drug Corp for TREMFYA 100 mg/ml, a pharmaceutical product, with an ultimate completion date of August 19, 2025. This competitive award, issued on August 18, 2025, represents a firm fixed-price delivery order with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- SPE2DB25D3109Indefinite Delivery Contract
- SPE2DB25D3109-SPE2DB25FP4MSDelivery Order
The Defense Logistics Agency awarded a $14,510.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TREMFYA 200 MG/2 ML pen injections on September 9, 2025, with completion targeted for September 30, 2025. This is a non-set-aside, competitively awarded contract supporting federal medical procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for military and veteran healthcare systems through its extensive portfolio of pharmaceutical products and medical supplies. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The underlying IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support Defense Health Agency operations and other government healthcare systems worldwide. The firm fixed-price structure and the company's demonstrated capability to fulfill federal medical supply requirements through open competition underscore its role as a primary pharmaceutical vendor within the DLA's supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.5k | 9/9/25 |